RYTM
Rhythm Pharmaceuticals Inc Earnings
$109.15
Earnings Summary
Revenue | $51.3Mn |
Net Profits | $-52.9Mn |
Net Profit Margins | -103.13% |
Rhythm Pharmaceuticals Inc’s revenue jumped 54.28% since last year same period to $51.3Mn in the Q3 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 5.76% jump in its revenue since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit fell -21.23% since last year same period to $-52.9Mn in the Q3 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -13.45% fall in its net profits since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit margin jumped 21.42% since last year same period to -103.13% in the Q3 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -7.27% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.69 |
EPS Estimate Current Year | -0.69 |
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.69 - a -2.6% fall from last quarter’s estimates.
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.69.
Key Ratios
Earning Per Share (EPS) | 0 |
Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Rhythm Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-04 | -0.69 | 0 | 100% |
2025-08-05 | -0.67 | -0.75 | -11.94% |
2025-05-07 | -2.16 | -0.81 | 62.5% |
